🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a one-arm, open, phase II clinical study, and the study subje...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2020-07
Trial ID
NCT04481932
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
To explore the real world data of trastuzumab Combined With Trastuzumab And...
Status
Unknown
Location
Multiple Locations
Start Date
2021-01-01
Trial ID
NCT04609540
Treatments Being Tested
This is a multi-center,randomized,phase 3 clinical trial. In the study, HER...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2021-02-02
Trial ID
NCT04736589
Treatments Being Tested
Given that pyrotinib has been proven to exert significant efficacy against ...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2026-07-06
Trial ID
NCT07600164
Treatments Being Tested
This prospective, response-guided phase II study investigates individualize...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-12-25
Trial ID
NCT07340398
Treatments Being Tested
This study is a prospective, single arm, multi-center clinical trial. The p...
Status
Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2024-12-03
Trial ID
NCT06832904
Treatments Being Tested
This is a randomized, open label Phase II-III neoadjuvant study comparing t...
Status
Active Not Recruiting
Location
Shengjing Hospital affiliated to China Medical University
Start Date
2022-05-23
Trial ID
NCT05426486
Treatments Being Tested
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER-1 and HER...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-09-15
Trial ID
NCT05346861
Treatments Being Tested